A groundbreaking paper in Nature describes a promising new therapy for obesity that leads to greater weight loss in mice than existing medications. The approach smuggles molecules into the brain's appetite centre and affects the brain's neuroplasticity.
Novo Holdings Portfolio Company Syndesi Therapeutics acquired by AbbVie· Deal value of US$ 1 billion with US$ 130 million upfront· Novo Holdings co-created Syndesi Therapeutics in partnership with UCB Pharma and co-led the Series A financing&m.
/PRNewswire/ Novo Holdings, a leading international life sciences investor, today announces that its portfolio company Syndesi Therapeutics ( Syndesi ) has.
Insights on the Peptide Therapeutics Global Market to 2030 – Key Industry Trends and Forecasts – ResearchAndMarkets com financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.